{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:33:25Z","timestamp":1789014805822,"version":"build-2803163510"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Quantification of serum free light chains (FLC) is important in the diagnosis of plasma cell diseases where an abnormal kappa:lambda ratio infers a population of monoclonal plasma cells. The Freelite\u2122 and N Latex assays have been validated in populations without kidney disease but there is a paucity of data relating to the use of these assays in end stage kidney disease (ESKD). The aim of the study was to compare FLC assay performance in ESKD patients on haemodialysis.<\/jats:p><jats:p>Cross-sectional multi-centre study comparing the performance of the two assays on 112 haemodialysis patients without known paraproteinaemia. We quantified FLC pre- and post-dialysis using both the N Latex and the Freelite assays.<\/jats:p><jats:p>FLC levels were elevated by both assays. Lambda FLC levels were considerably higher by the N Latex assay. Using the proposed renal reference range for Freelite (0.37\u20133.1) all but one patient had normal kappa:lambda FLC ratios. In contrast, there were no abnormal FLC ratios pre-dialysis using the N Latex assay. This was due to lambda FLC reading significantly higher by the N Latex assay. Kappa and lambda FLC levels decreased with dialysis but remained elevated above the normal range. The excess of lambda FLC by N Latex persisted post-dialysis but was somewhat attenuated. Dialysis adequacy and dialysis modality predicted clearance of kappa and lambda FLC by both assays.<\/jats:p><jats:p>The N Latex assay reported significantly higher pre-dialysis lambda FLC concentrations compared with the Freelite assays. Clinicians should be aware of the need for a separate renal reference range for interpreting FLC ratio using the Freelite assay but not for the N Latex assay in ESKD patients.<\/jats:p>","DOI":"10.1515\/cclm-2015-0799","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T17:02:20Z","timestamp":1450458140000},"source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Freelite\u2122 and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis"],"prefix":"10.1515","volume":"54","author":[{"given":"Alice","family":"Kennard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mollee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref21","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","year":"2001","journal-title":"Blood"},{"key":"ref101","first-page":"981","article-title":"Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref301","first-page":"621","article-title":"Serum free light chain assessment in monoclonal gammopathy and kidney disease","volume":"11","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","year":"2008","journal-title":"BMC Nephrol"},{"key":"ref201","first-page":"489","article-title":"Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis","volume":"50","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbapap.2010.12.012","article-title":"A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum","volume":"1814","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref41","first-page":"489","article-title":"Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis","volume":"50","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref81","first-page":"S41","article-title":"Comparison of the Freelite and N Latex srum free light chain (FLC) assays in chronic kidney disease [abstract]","volume":"33","year":"2012","journal-title":"Clin Biochem Rev"},{"key":"ref311","first-page":"e243","article-title":"Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref161","first-page":"167","volume-title":"Serum free light chain analysis","year":"2008"},{"key":"ref241","first-page":"S41","article-title":"Comparison of the Freelite and N Latex srum free light chain (FLC) assays in chronic kidney disease [abstract]","volume":"33","year":"2012","journal-title":"Clin Biochem Rev"},{"key":"ref71","first-page":"853","article-title":"N Latex FLC serum free light-chain assays in patients with renal impairment","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.2006080821","article-title":"Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies","volume":"18","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","year":"2009","journal-title":"Leukemia"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","year":"2001","journal-title":"Blood"},{"key":"ref151","first-page":"e243","article-title":"Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis","volume":"119","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"ref01","first-page":"167","volume-title":"Serum free light chain analysis","year":"2008"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","year":"2008","journal-title":"BMC Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis","volume":"119","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbapap.2010.12.012","article-title":"A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum","volume":"1814","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref141","first-page":"621","article-title":"Serum free light chain assessment in monoclonal gammopathy and kidney disease","volume":"11","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.2006080821","article-title":"Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies","volume":"18","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","year":"2009","journal-title":"Leukemia"},{"key":"ref231","first-page":"853","article-title":"N Latex FLC serum free light-chain assays in patients with renal impairment","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref261","first-page":"981","article-title":"Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0799\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:50:50Z","timestamp":1619049050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0799\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":28,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0799","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}